News
News
Compound targets mutated DLBCL, WM cells
SAN DIEGO—A Toll-like receptor (TLR) antagonist can target B-cell lymphoma cells harboring the MYD88 L265P mutation, preclinical research suggests...
News
FDA approves ofatumumab in combination for CLL
Credit: Linda Bartlett The US Food and Drug Administration (FDA) has approved ofatumumab (Arzerra) in combination with chlorambucil for...
News
Groups investigate malaria complications in children
Credit: Peter H.
News
Agent can reduce ESR in SCD, study suggests
Credit: Graham Colm MIAMI—Results of a small study suggest an experimental agent can decrease the erythrocyte sedimentation rate (ESR) in...
Article
Measuring patient flow in a children's hospital using a scorecard with composite measurement
News
FDA discourages use of laparoscopic power morcellation during hysterectomy and myomectomy
Hospitals suspend use of power morcellators until further notice
Article
The Use of Secure Messaging in Medical Specialty Care
The benefits of improving communication between health care providers and patients outweigh secure messaging’s implementation challenges.
News
Reovirus shows synergy with agents used to treat MM
Six of the 7 MM cell lines tested were at least moderately sensitive to reovirus, and introducing the virus in combination with the proteasome...
News
Protective cells are impaired in aggressive CLL
Credit: Monash University New research may explain why patients with chronic lymphocytic leukemia (CLL) are vulnerable to severe, recurrent...